diosgenin has been researched along with Colitis Gravis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, H; Li, S; Liu, J; Nie, B; Pang, B; Qu, S; Xu, J; Yang, M; Zhang, K | 1 |
| Cai, J; Cao, Y; Dong, X; Fan, P; Liu, J; Liu, X; Zhang, N; Zhu, K | 1 |
| Huang, BY; Mai, CT; Wang, CL; Wang, QM; Wang, TT; Wu, MM; Zhang, XJ | 1 |
3 other study(ies) available for diosgenin and Colitis Gravis
| Article | Year |
|---|---|
Dioscin promotes autophagy by regulating the AMPK-mTOR pathway in ulcerative colitis.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Colitis, Ulcerative; Colon; Dextran Sulfate; Diosgenin; Disease Models, Animal; Mice; TOR Serine-Threonine Kinases | 2022 |
Dioscin prevents DSS-induced colitis in mice with enhancing intestinal barrier function and reducing colon inflammation.
Topics: Animals; Colitis, Ulcerative; Colon; Dextran Sulfate; Diosgenin; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Intestinal Mucosa; Male; Mice | 2021 |
Dioscin ameliorates murine ulcerative colitis by regulating macrophage polarization.
Topics: Animals; Anti-Inflammatory Agents; Colitis, Ulcerative; Colon; Cytokines; Dextran Sulfate; Diosgenin; Disease Models, Animal; Hypoxia-Inducible Factor 1, alpha Subunit; Macrophages; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Inbred BALB C; PPAR gamma; RAW 264.7 Cells | 2021 |